Fgfr Inhibitors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fgfr inhibitors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fgfr Inhibitors Today - Breaking & Trending Today

Monitoring and Managing Hyperphosphatemia

Hyperphosphatemia is the most common AE associated with FGFRi treatments and can impact patient quality of life, but there are treatments and possible diet changes that may help mitigate this AE. ....

Chaundra Bishop , R Katie Kelley , Caroline Kuhlman , Lipika Goyal , Taiho Oncology Inc , Taiho Oncology , Onclive Insights , Bile Duct Cancer , Biliary Tract Cancer , Intrahepatic Cholangiocarcinoma , Extrahepatic Cholangiocarcinoma , Adverse Events , Fgfr Inhibitors , Fgfr Inhibitors Adverse Effects , Patient Monitoring ,

Patient Perspective Regarding FGFRi Adverse Event Profiles

A patient with cholangiocarcinoma shares her experience while being treated with an FGFR inhibitor, as well as insights on what providers should tell their patients to help them best manage or possibly prevent these adverse events. ....

Chaundra Bishop , Caroline Kuhlman , Lipika Goyal , R Katie Kelley , Onclive Insights , Bile Duct Cancer , Intrahepatic Cholangiocarcinoma , Extrahepatic Cholangiocarcinoma , Fgfr Inhibitors , Fgfri Adverse Events , Adverse Events , Fgfr Inhibitors Adverse Effects , Fgfr Inhibitors Side Effects , Biliary Tract Cancer ,